Our vision for HUPO2017 Congress on “Integrated Proteomics for Healthcare Systems” is to create a meeting that will bring together world leaders with a new generation of scientists to promote HUPO’s capabilities for advancing our knowledge of the Human Proteome and the impact this will have on our understanding of health, disease and ageing. The Congress will celebrate past achievements and present new disruptive advances in proteomics. This will be achieved by a balanced scientific programme that takes into account previous milestone developments in proteomics, the current state of the art as well as newly arising areas and opportunities.
The programme will include key outreach events as well as sessions devoted to each of the twelve (12) current HUPO Initiatives and to the three (3) pillars of the HPP.
In recognition of the increasing role of proteomics in medicine development and point of care testing, and the consequential impact on the biopharmaceutical industry, we will have a special focus on the application of proteomics in clinical trials, therapeutic protein production and disease diagnosis, including opportunities for brainstorming and networking to provide solutions in global healthcare.
The 16th World Congress of the Human Proteome (HUPO 2017) covers topics such as:
Cancer & Translational Proteomics
Antibodies and Protein Arrays
Chemical Proteomics & Profiling Drug Targets
Chemical Probes & Chemical Biology for Proteomics
Diabetes & Cardiovascular Diseases: Energy balance in disease phenotypes (HPP)
Cys Modifications & Redoxomics
Food & Nutrition and Immuno-Peptidome: Focus on food allergies (HPP)
Extracellular & Membrane Proteomics
Imaging & Single Cell Proteomics
Glycoproteomics - Technical Limitations & Prospects
Innovative MS Techniques for Global & Targeted Proteomics
Immunity, Inflammation & Infectious Diseases
Interactomics & Protein Network
Integrative Glyco(proteo)mics for Glycosylation Disorders
Liver & Toxicoproteomics: Metabolism, drug transformation & toxicity (HPP)
Kidney, Urine & Plasma: Opportunities for early diagnosis and risk assessment (HPP)
MS Informatics & Mining Multivariate Proteomic Datasets
Metabolomics & Metabolic Disorders
New Technological Advancements
Neurological Disorders & Brain Proteomics
Plant & Microbial Proteomics
Pharmacoproteomics & Drug Discovery
Proteogenomics & The Missing Proteins/peptides
Protein Standards & Model Organisms: Expanding our horizons (HPP)
PTM Crosstalks I - Phosphoproteomics, Kinome & OGlcNAc
Proteome Dynamics: Turnover & Degradomics
Spatial Proteomics
PTM Crosstalks II - Lysine & other modificomics
09月17日
2017
09月20日
2017
摘要截稿日期
注册截止日期
留言